Objective: Elevated levels of inflammation factors often precede weight loss and may be causally related to it. Newer studies suggest that elevated levels of inflammation factors also precede weight gain. In this study, we examined whether inflammation factors are elevated in individuals, age X65 years, who lost or gained 45% weight over a 3 year follow-up period compared to those with stable weight. Subjects: In total, 3254 participants in the Cardiovascular Health Study whose weight was stable; 661 who gained 45% weight; and 842 who lost 45% weight. Measurements: C-reactive protein (CRP), fibrinogen, factor VIIIc, white blood cell (WBC) and platelet counts, and interleukin-6 (IL-6) levels. Results: As compared to participants whose weight was stable, those who lost 45% weight had higher baseline CRP concentration (1.05 (95% CI, 1.02, 1.08) per interquartile increase) and WBC count (1.10 (1.01, 1.19) per interquartile increase) on adjusted analyses. Those who gained 45% weight had higher baseline CRP (1.05 (1.01, 1.08)), fibrinogen (1.13 (1.01, 1.27)), and factor VIIIc (1.15 (1.03, 1.30)). Conclusions: Inflammation factors are associated with weight gain and weight loss in older individuals. These findings suggest that subclinical inflammation, or unknown factors associated with subclinical inflammation, contribute to weight change.
Introduction
Elevated levels of inflammation factors can be associated with diminished appetite and weight loss, especially in the context of chronic disease. [1] [2] [3] [4] Recently, it has been shown that elevated levels of inflammation factors can also predate weight gain. 5 The Atheroscerosis Risk in Communities (ARIC) Study and the Healthy Women Study reported elevated concentrations of fibrinogen and C-reactive protein (CRP) before weight gain. 6, 7 A study from Malmö, Sweden demonstrated that the greater the number of elevated inflammation proteins, the greater the odds of subsequent weight gain. 8 Until these studies appeared, it was assumed that elevated levels of inflammation factors in obese individuals arise in response to cytokines secreted from adipose tissue and do not precede weight gain or obesity. 9 In order to clarify the relationship of inflammation factors with weight change in older adults, we analyzed the association of inflammation factors with weight loss and weight gain over a 3-year period of time among participants in the Cardiovascular Health Study (CHS). The study contains detailed information about weight change and markers of inflammation, and information regarding conditions which can increase inflammatory factors, such as clinical and subclinical CVD, 10 fat intake, 11 physical inactivity, 12 smoking, 13 and glucose disorders. 14 It also contains information on health and behavioral factors known to affect weight, such as physical inactivity and caloric intake, which could be in the causal pathway(s) for weight change. We hypothesized that elevated inflammation factors predate both weight gain and weight loss.
Materials and methods
The Cardiovascular Health Study is an observational study of adults, age X65 years, which seeks to determine risk factors for cardiovascular disease (CVD). Recruitment methods have been published. 15 In brief, a random sample of individuals, X65 years of age, derived from Medicare eligibility lists, and their spouses, were invited to participate at four field centers. Potential participants were excluded if they were institutionalized, had cancer under active treatment, required a proxy respondent, or were expected to move from the area within 3 years. In total, 5201 participants were enrolled in [1989] [1990] (called the original cohort) and 687 in 1992-1993 to provide additional representation of Blacks (called the new cohort). Semiannual follow-up alternating between clinical examination and telephone interview occurred thereafter. All participants signed informed consent on study entry. Participants for this study included those with weight measured at the baseline and third annual examinations. This included 4256 participants from the original cohort, and 501 from the new cohort. Of the original cohort, 6.7 and 8.2% in the new cohort had died by the time of the third examination, and 18.2 and 27.1%, respectively, had only a telephone interview and did not have their weight measured.
Laboratory tests and information on caloric intake, alcohol consumption, smoking, energy expenditure, clinical and subclinical CVD, and socio-economic status, activities of daily living (ADLs) and instrumental activities of daily living (IADLs) were obtained as previously described. [16] [17] [18] Percent change in body weight over the 3-year follow-up period was calculated as the difference between weights divided by the original weight. Significant weight change was classified as either a 45% increase or decrease. Stable weight was defined as 75% of baseline weight. 1 
Statistical analyses
Baseline characteristics of groups categorized by weight gain and loss, were compared using the w 2 test for discrete values and the t-test for continuous data. Nonparametric testing was used for skewed values. Logistic regression models were used to examine the association of individual markers of inflammation with weight change.
Results
Baseline factors (Table 1 ) As compared to participants whose weight was stable, those who lost 45% weight were older, more likely to be women, nonwhite, have less education, to not be a former smoker, to have greater body mass index (BMI) and waist circumference, to have more clinical and subclinical CVD, hypertension, and diabetes. They also had poorer self-assessed health, higher depression scores, lower energy expenditure, a greater frequency of individuals with difficulty walking and impairments in ADLs and IADLs, and lower mini-mental scores.
Those who gained 45% weight were younger, more likely women, more likely to be current smokers or to cease smoking during follow-up, and to be less heavy than those whose weight remained stable. They were less likely to report excellent health, had higher depression scores, more difficulties with IADLs, and reported less fat intake. They had higher HDL cholesterol levels. The higher HDL levels were due to the higher proportion of women in the weight gain group (HDL women B59 mg/dl; men B48 mg/dl).
Baseline levels of inflammation factors (Table 2 ) Participants who lost 45% weight during follow-up had higher baseline CRP, fibrinogen, factor VIIIc, and interleukin-6 (IL-6) levels, and higher WBC counts as compared to those with stable weight. Those who gained 45% weight during follow-up had higher CRP, fibrinogen, and factor VIIIc levels, and higher WBC and platelet counts at baseline.
Follow-up events (Table 3)
Among those who lost 45% weight during follow-up, the weight loss averaged 9.1% of the baseline weight. Among those who gained 45% weight, the amount gained averaged 8.7%. Those who lost weight were more likely to develop cancer or have a CVD event than those who had stable weight. No such associations were seen in those who gained weight.
Odds ratios for 45% weight loss or gain by inflammation factors (Table 4) On unadjusted analyses, the odds of losing 45% weight on follow-up increased with each interquartile range higher value of baseline CRP, fibrinogen, factor VIIIc and IL-6 levels, and the WBC count. Adjustment for age, gender, race, and BMI at baseline left significant associations for CRP, IL-6 and WBC count. Further adjustment for baseline hypertension status, fasting glucose status, impairment in IADLs, hospitalization on follow-up, and smoking cessation during followup, left significant associations with CRP and WBC count, and a borderline association with IL-6. A higher baseline platelet count was associated with lower odds of losing 45% weight.
In unadjusted analyses, the odds of gaining 45% weight on follow-up were increased with each interquartile range higher value of baseline CRP, fibrinogen, and factor VIIIc levels, and the WBC and platelet counts. Adjustment for age, gender, race, and baseline BMI left significant associations for CRP, fibrinogen, factor VIIIc and the WBC count. Further adjustment for hypertension status, fasting glucose status, impairment in IADLs, and smoking cessation during followup, left significant associations with CRP, fibrinogen, and factor VIIIc levels.
None of the tests of interaction of inflammatory markers for weight loss (CRP level, WBC and platelet counts) and for weight gain (CRP, fibrinogen, and factor VIIIc levels) with the following baseline factors (in separate models) were statistically significant: fasting glucose status (diabetes mellitus (DM) or impaired fasting glucose vs normal), 15 for details). b ADL, limitation of activities of daily living is defined as difficulty with self-care, such as bathing, feeding, going to the toilet, dressing, grooming and taking medications. c IADL, limitation of instrumental activities of daily living is defined as trouble performing any of the following: light or heavy housework, shopping, meal preparation, money management, and using the telephone.Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; IFG, impaired fasting glucose; LDL, low-density lipoprotein. Inflammation factors and weight change JI Barzilay et al hypertension (yes vs no), obesity (BMI429.9 vs p29.9), hospitalization during follow-up (yes vs no), incident CVD event during follow-up (yes vs no), and metabolic syndrome (NCEP ATP criteria) (yes vs no). Interaction terms between inflammation factors and race were also nonsignificant with one exception. There was a significant interaction between race and CRP for weight gain vs stable weight. For Whites who gained weight the fully adjusted odds ratio per interquartile higher baseline CRP was 1.06 (95% CI, 1.02, 1.10), whereas for Blacks who gained weight it was 1.003 (0.92, 1.09). Further analysis showed that, in general, Blacks had a lower degree of association between inflammation factors and weight gain than did Whites (Appendix).
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Discussion
In this 3-year longitudinal study, participants with higher levels of baseline inflammation factors were more likely to have 45% weight loss or 45% weight gain during follow-up as compared to participants whose weight remained stable. These results were present whether or not conditions associated with increased levels of inflammation factorsobesity, prevalent CVD, or glucose disorders -were present or not, and after taking into account factors associated with weight change, such as total caloric intake. These results suggest that innate biological factors may impact weight change in either direction.
The role of inflammation in weight loss has been examined in association with chronic medical conditions such as renal disease, COPD, heart failure, and cancer. 4 Defects in hypothalamic control of appetite in response to inflammation factors have been proposed as the underlying cause for the weight loss. 19 The mechanism(s) by which inflammation may lead to weight gain are less certain. It is possible that many of the same stimuli that suppress appetite may act to stimulate appetite when presented to the feeding and satiety centers of the hypothalamus under different circumstances. For example, inflammation factors arising from cancer cells may suppress appetite, whereas those arising from the crosstalk between adipocytes and monocytes in adipose tissue may stimulate appetite. 20 In this study, CRP levels were related to both weight gain and weight loss. Others speculate that chronic stimulation of the sympathetic nervous system by inflammation-related factors leads to obesity. 21 It is also possible that inflammation factors are not related to weight gain. Rather, they act as surrogate markers of other processes associated with weight change that were not measured in our analyses. Several other points from our analyses should be noted, although they were not the focus of our study. First, it is commonly believed that older adults are much more prone to lose weight than to gain weight. This was not the case in this study (18.9% lost weight, 13.9% gained weight). We also found that depression in older adults was more strongly associated with weight gain than with weight loss. Second, similar to studies of younger adults, smoking cessation was accompanied by weight gain in older adults. Third, of those who gained weight, a large percentage had normal weight (BMIo25) at baseline. This suggests that in older age, as in younger age, it is difficult to maintain optimal weight. Fourth, those who gained weight did not consume any more total or fat calories, imbibe more alcohol, expend less energy, or have more difficulty walking 1 2 mile than those whose weight remained stable (although they did stop smoking more often). These findings are consistent with the possibility that other factors -such as those described here -are responsible, in part, for weight gain. Last, we found that the effects of inflammation factors on weight gain differed somewhat by race. Higher baseline CRP levels, as well as levels of other inflammation factors, were not as strongly associated with weight gain in Blacks as they were in Whites. Two prior studies have shown that inflammation factors are less powerful predictors of diabetes -a condition frequently associated with overweight -in Blacks than in Whites. 22, 23 The mechanism(s) for this racial difference are unknown. It is possible, however, that the small numbers of Blacks in our cohort may have precluded sufficient power to attain statistical significance.
This study has several strengths. It examined and controlled for baseline weight, health, physical activity and cardiovascular risk factors that could have influenced levels of inflammation factors. The follow-up period was relatively short (3 years), and not as long as in the Healthy Women Study (8 years) or the Malmö Preventive Study (6 years). This minimizes dilution of the effect that inflammation factors might have on weight change. The study also examined Whites and Blacks. Last, CHS excluded individuals with serious chronic illnesses that could have lead to early death. As such, our findings with regard to weight loss are not biased by the inclusion of people with terminal illnesses. Disadvantages of this study include lack of information regarding whether or not weight loss was intentional. Also, weight was measured only at two points in time, so that a trajectory of weight change could not be computed and its impact on our findings assessed.
In conclusion, we found that inflammation factors, or factors as yet to be identified that associate with subclinical inflammation, predict weight loss and weight gain in the elderly. Of interest is the fact that in previous CHS analyses, elevated CRP levels predicted diabetes, a condition strongly related to weight gain. 13 This suggests that weight gain and diabetes may be related to one another by a common factor that raises CRP levels. Further study at the laboratory and population level is needed.
